a story lives forever
Register
Sign in
Form submission failed!

Stay signed in

Recover your password?
Register
Form submission failed!

Web of Stories Ltd would like to keep you informed about our products and services.

Please tick here if you would like us to keep you informed about our products and services.

I have read and accepted the Terms & Conditions.

Please note: Your email and any private information provided at registration will not be passed on to other individuals or organisations without your specific approval.

Video URL

You must be registered to use this feature. Sign in or register.

NEXT STORY

Working on making the first oral contraceptive

RELATED STORIES

The race to synthesise cortisone
Carl Djerassi Scientist
Comments (0) Please sign in or register to add comments
So we entered this race for cortisone, which really no one knew that we were even players in this field. And when I say race it was very typical. It really was that and to make a long story short we won that race. Now, that is in many respects a meaning, meaningless statement because what does that mean? And yet that’s the terminology we use in science all the time, particularly in synthetic chemistry. Who is first? Now, the rest of the world really couldn’t care less because why should any patient care who was the first to make cortisone. They’re interested in getting cortisone. They’re interested in getting it the cheapest way. So therefore they want to have the cheapest synthesis. That does not necessarily mean the first synthesis, but for scientists it was the first. And we were first by a few weeks. So that’s all. So that makes really no difference and in fact there were four communications to the editor published in one issue. The August 1951 issue of the "Journal of the American Chemical Society", the most prestigious chemical journal. Of two communications from Harvard, one from Merck, and one from Mexico City from a place that really very few people had heard of before. But of course you have submission dates there and ours was the earliest one, and that put us on the map. There were newspaper articles and pictures in "Life" magazine, and this is the picture they actually showed, which is a very funny and amusing one here because you can see us right here. So there we’re sitting, the team, around a table mesmerised by this big root in the middle, which is really this dioscorea root from which we prepared diosgenin. And then George Rosenkranz is sitting there in the middle. These are two people, well, who have no lab jackets. I’m there and George Rosenkranz is here, and holds a vial. In there presumably there was supposed to be cortisone. Of course we, we’d made a few milligrams so this was sugar that was in there. This was for "Life" magazine, but it really, it put Syntex on the map. We did a lot of other work as well, but this was really actually quite sensational because it was done in a rather short period of time. You know, in not quite a year, which for this sort of thing was quite an accomplishment.

Austrian-American Carl Djerassi (1923-2015) was best known for his work on the synthesis of the steroid cortisone and then of a progesterone derivative that was the basis of the first contraceptive pill. He wrote a number of books, plays and poems, in the process inventing a new genre, 'science-in-fiction', illustrated by the novel 'Cantor's Dilemma' which explores ethics in science.

Listeners: Tamara Tracz

Tamara Tracz is a writer and filmmaker based in London.

Tags: Journal of the American Chemical Society, Harvard, Life Magazine, Ed Mereck

Duration: 2 minutes, 20 seconds

Date story recorded: September 2005

Date story went live: 24 January 2008